MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal disorder characterized by the progressive loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. Sporadic ALS form accounts for the majority of patients, but in 1⁻13.5% of cases the disease is inherited. The...
Main Authors: | Claudia Ricci, Carlotta Marzocchi, Stefania Battistini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/7/11/219 |
Similar Items
-
BDNF and Pro-BDNF in Amyotrophic Lateral Sclerosis: A New Perspective for Biomarkers of Neurodegeneration
by: Giulia Riolo, et al.
Published: (2022-05-01) -
Opportunities Offered by Graphene Nanoparticles for MicroRNAs Delivery for Amyotrophic Lateral Sclerosis Treatment
by: Benedetta Niccolini, et al.
Published: (2021-12-01) -
Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity
by: Rachel Waller, et al.
Published: (2018-01-01) -
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
by: Jinmeng Liu, et al.
Published: (2022-02-01) -
Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study
by: Francesca Pregnolato, et al.
Published: (2021-08-01)